Last reviewed · How we verify

NCT06080412: BLUEMR

Blueprint® Mixed Reality Pilot Study

Completed Last updated 16 September 2025
What this trial tests

trial in Orthopedic Disorder in 44 participants. Completed in 7 May 2025.

Timeline
8 February 2024
Primary endpoint
14 August 2024
7 May 2025

Quick facts

Lead sponsorStryker Trauma and Extremities
StatusCompleted
Study typeOBSERVATIONAL
Enrollment44
Start date8 February 2024
Primary completion14 August 2024
Estimated completion7 May 2025
Sites4 locations across France

Conditions studied

Sponsor

Stryker Trauma and Extremities — full company profile →

Who can join

18 and older, any sex, with Orthopedic Disorder or Arthritis Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A pilot Single-Arm, Multicenter, Prospective, Post-Market 6 months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINT™ (HOLOBLUEPRINT™).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Orthopedic Disorder

Currently open trials in the same condition.

Other Stryker Trauma and Extremities trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06080412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing